What Аэрофиллин Treats: Main Uses and Benefits

The therapeutic relevance of Аэрофиллин (Theophylline) is recognized for situations where additional symptomatic support is needed for long-term respiratory difficulties. This medication is generally applied across domains where management of chronic airway conditions is required.

Stabilizing Breathing and Managing Symptom Load

It is commonly used across conditions presenting with recurrent or episodic manifestations, notably asthma, Chronic Obstructive Pulmonary Disease (COPD), and to manage apnea of prematurity in infants. The medication is applied in addressing symptom clusters that may appear suddenly or fluctuate, such as persistent wheezing, recurrent shortness of breath, and uncomfortable chest tightness.

It is considered relevant in clinical settings marked by heightened patient distress, often used as an add-on therapy when symptoms intensify and supportive relief is needed. The medication contributes to improved comfort during periods of heightened symptoms, helping patients cope more steadily with symptom fluctuations.

---

Quick Fact: Relief for Respiratory Distress

Symptom Domain	Target Condition	Patient Benefit
Airflow Obstruction	COPD, Asthma	Contributes to easing the overall symptom load
Acute/Severe Distress	Breakthrough Symptoms	Supports patients during difficult episodes
Irregular Breathing	Apnea of Prematurity	May assist with maintaining functional stability

Regulatory References

1. NIH MedlinePlus Drug Information

Eligibility Map: Who can and cannot use Аэрофиллин (Theophylline) — official regulatory information

---

Eligibility Scope

Classification	Population/Condition	Restriction Statement
Absolute Contraindication	Hypersensitivity	Must not be used by patients with a history of allergy to theophylline or other xanthine derivatives [2.1].
	Comorbidity	Use prohibited in patients with Porphyria (in some regional labeling).
Age Restriction	Infants	Use contraindicated in children under 6 months of age (in some regional labeling) [3.3].
Restricted Use	Hepatic Impairment	Use with caution in patients with liver disease (e.g., cirrhosis) as drug clearance is significantly decreased [2.1, 3.1].
	Cardiovascular Status	Use with caution in patients with cardiac arrhythmias, acute pulmonary edema, or cor pulmonale [1.2, 3.1].
	Systemic Illness	Requires caution during sustained high fever (geq102 F for geq24 hours) or severe infection [1.2, 2.1].
Age-Related Caution	Older Adults (>60)	May be more sensitive to effects due to slower clearance and coexisting conditions; dose adjustment and monitoring required [1.2, 2.1].
	Young Children	Children under 1 year of age may be at greater risk of serious side effects and require caution [1.2].
Conditional Status	Pregnancy	US FDA Pregnancy Category C. Use is not recommended unless clearly necessary, due to a lack of controlled human studies [2.2].
	Lactation	Theophylline is secreted in breast milk. Use is generally acceptable, but caution and monitoring for infant side effects (e.g., irritability) are recommended [4.3].

---

Official Eligibility Statements

• Contraindicated in patients with known hypersensitivity to theophylline or other xanthine derivatives [2.1].
• Use with caution in populations with conditions that reduce drug clearance, including those with liver dysfunction, congestive heart failure, or sustained high fever [3.1].
• Eligibility is highly dependent on age, with infants under six months potentially excluded and older adults requiring special consideration due to increased sensitivity [1.2, 3.3].

Connection to the overall eligibility profile: Official regulatory documents define who can and cannot use this medicine by establishing absolute contraindications and defining restricted-use populations based on physiological conditions—like hepatic impairment or advanced age—that compromise the body's ability to clear the drug. These constraints ensure the drug is reserved for patients where the risk of accumulated toxicity from variable clearance is mitigated or absent.

The official regulatory profile for Theophylline (Аэрофиллин) strictly documents numerous interactions that modify drug exposure or result in pharmacodynamic changes. Co-administration with specific medications is formally restricted.

Riociguat and Febuxostat are classified as contraindicated combinations due to the resulting risk of additive hypotension or significantly increased Theophylline plasma levels, respectively. The use of Fluvoxamine should also be avoided due to the documented reduction in Theophylline clearance.

The drug's clearance is subject to modification by various other substances. Medications like Cimetidine, Ciprofloxacin, and Macrolide antibiotics (e.g., Erythromycin) are documented to reduce Theophylline clearance, increasing the potential for elevated blood concentrations. Conversely, agents such as Phenytoin, Carbamazepine, and Rifampicin are noted to increase clearance, which may lead to reduced drug exposure.

Pharmacodynamic interactions are also documented, including the potentiation of effects from β-adrenergic agonists and the official antagonism of adenosine receptor agonists. Furthermore, the regulatory profile details how certain non-medicinal substances alter drug exposure: smoking, alcohol consumption, and the herbal product St. John’s Wort are all documented to increase Theophylline clearance.

Finally, mandatory constraints include the need to separate the administration of Theophylline from enteral (tube) feedings by one hour before and one hour after the dose to ensure proper absorption.

The Pharmacodynamic Mechanism of Аэрофиллин

The primary action of this compound involves non-selective competitive inhibition of Phosphodiesterase (PDE) enzymes, predominantly isoforms PDE3 and PDE4. By inhibiting PDE, the drug prevents the hydrolysis of intracellular cyclic adenosine monophosphate (cAMP), leading to elevated cAMP concentrations. This sustained cAMP signaling cascade promotes relaxation of the smooth muscle tissue in the bronchi, which consequently modifies airway tone.

Simultaneously, the drug acts as a non-selective antagonist at various adenosine receptors (A1, A2A, A2B). This antagonism blocks the physiological effects normally elicited by adenosine, which directly reduces the release of certain pro-inflammatory mediators and reinforces the effect on smooth muscle relaxation.

A distinct action involves the restoration of Histone Deacetylase 2 (HDAC2) function, particularly when impaired by cellular oxidative stress. The restored HDAC2 activity suppresses the gene expression of inflammatory proteins, influencing both inflammatory pathway activity and mediator levels at the cellular level.

How Аэрофиллин is Used: Administration and Dosing Principles

Administration of Аэрофиллин (Theophylline) is designated for either long-term maintenance or short-term acute use. The choice of form and administration route depends on clinical requirements.

Administration Scope

The medication is administered via two official routes:

• Oral: For sustained, long-term maintenance, using immediate-release or extended-release tablets/capsules.
• Intravenous (IV): Reserved for acute episodes where rapid therapeutic action is required, necessitating supervised administration in a clinical setting.

Dosing and Scheduling

Standard adult oral dosing typically begins with a low dose, such as 300 mg per day, divided, and is gradually titrated (adjusted) upward. The usual daily maintenance dose may range up to 600 mg in healthy adults, but adjustments are guided by serum theophylline concentration monitoring to keep levels within the target therapeutic range. IV administration involves a calculated loading dose (e.g., 5 mg/kg over 20 to 30 minutes) followed by a continuous maintenance infusion.

Preparation and Procedural Rules

Standard protocols for proper use include:

• Extended-Release Forms: These tablets must be swallowed whole and must not be crushed, broken, or chewed to avoid rapid, uncontrolled drug release. They may be taken with or without food, but consistent timing relative to meals is encouraged for stable absorption.
• Age and Impairment: Dosing requires modification in specific populations. Older adults typically require lower maintenance doses (e.g., generally no more than 400 mg per day) due to reduced clearance, and patients with hepatic impairment require substantial dose reduction.
• Missed Doses: If a scheduled oral dose is missed, it should be taken if remembered within 4 hours of the scheduled time; otherwise, the missed dose is skipped, and the regular schedule is resumed.

The overall use protocol requires that oral therapy is designed for long-term use, while IV administration is confined to short-term, acute intervention, with both protocols being reliant on therapeutic drug monitoring.

Evidence for Use in Chronic Obstructive Pulmonary Disease (COPD)

Research has examined Аэрофиллин (Theophylline) for individuals managing Chronic Obstructive Pulmonary Disease (COPD), often exploring its use as an add-on medication alongside inhaled therapies. Studies have primarily been Randomized Controlled Trials (RCTs) and observational cohorts. Researchers monitored lung function measures (such as FEV1 and FVC), as well as outcomes related to physical discomfort and daily functioning using patient-reported scores.

In these research settings, some trials reported measurements of modest changes in lung function compared to a placebo. Findings reported measurements related to systemic or functional imbalance, particularly in older evidence. However, findings were mixed regarding a consistent effect on the frequency of severe COPD exacerbations and related hospital admissions when comparing Аэрофиллин to standard care in contemporary trials.

Evidence for Use in Chronic Asthma

Аэрофиллин was studied for the long-term management of chronic asthma symptoms in both adults and children. Researchers examined how the medicine affected measures of airflow obstruction and the need for rescue medication. Studies reported measurements related to daily symptom intensity and the use of rescue medication when theophylline was used alongside other treatments. The intravenous form was evaluated in settings focusing on acute or disruptive episodes where researchers examined temporary physiological imbalance.

Evidence for Use in Apnea of Prematurity (AOP)

Research has explored the use of Аэрофиллин to manage apnea of prematurity in infants. Researchers monitored outcomes such as the rate of apneic episodes and the need for respiratory support. Research describes patterns showing measurements related to the rate of apneic episodes compared to those who received no treatment. Comparative trials with caffeine observed patterns related to a specific marker of physiological strain (tachycardia) in some studies with Аэрофиллин.

What is Still Uncertain About Аэрофиллин Evidence

The evidence presents several areas where research is ongoing or where certainty remains low. Comparative evidence is lacking between Аэрофиллин and the newest standard inhaled medications for many chronic outcomes. The follow-up durations were limited in many key studies, meaning the long-term effects are not fully established regarding durability of response and changes to the underlying condition’s course.

Key Studies & References

1. NIH MedlinePlus Drug Information: Theophylline
2. Efficacy and safety of theophylline in COPD: a systematic review and meta-analysis of randomized controlled trials

Common questions about Аэрофиллин (FAQ)

Q: Can Аэрофиллин be used long-term?

A: Yes, official administration guidelines describe the oral forms of Аэрофиллин (Theophylline) as intended for sustained, long-term maintenance use in managing chronic respiratory conditions. Due to its classification as a Narrow Therapeutic Index (NTI) drug, official regulatory documents indicate that monitoring of serum concentration may be necessary for patients receiving long-term therapy.

Q: How quickly should I expect to feel the effects of Аэрофиллин?

A: The onset of action depends on the form taken. For immediate-release oral tablets, peak concentrations are described as typically occurring about 1 to 2 hours after administration.

When administered intravenously (IV) in a clinical setting, the drug begins acting rapidly, with peak blood levels typically reached within 30 minutes.

Q: How long does the effect of Аэрофиллин usually last?

A: The effect is described as highly variable due to individual factors such as age, smoking status, and liver function. In certain adult populations, the time for half of the drug to be eliminated is indicated to be approximately 8.7 hours.

The extended-release formulations are specifically designed to provide a sustained effect suitable for long-term daily maintenance.

Q: Is Аэрофиллин available over the counter?

A: No, the active ingredient Theophylline is officially classified by regulatory bodies as a prescription-only (Rx) medication. It requires a medical prescription for dispensing.

Q: Is it true that Аэрофиллин requires dose adjustments based on weight?

A: Yes, regulatory dosing guidelines for intravenous administration involve calculating an initial loading dose based on the patient's body weight in kilograms. Dosing for children is also commonly based on body weight for therapeutic management.

Q: What happens if a dose of Аэрофиллин is missed?

A: Regulatory guidance for missed oral doses is generally to take the missed dose if remembered within a certain time frame (often four hours) of the scheduled time, or to skip it and resume the regular schedule.

If a dose is missed, official information indicates that patients should consult with a healthcare professional for guidance.

Q: Does Аэрофиллин affect sleep?

A: Yes, official product information lists insomnia (trouble sleeping) as a common adverse reaction associated with the medicine. Other nervous system effects that may affect rest include restlessness and irritability.

Q: Can I take other vitamins or supplements while using Аэрофиллин?

A: Official documentation details specific interactions with certain supplements, such as St. John’s Wort, which can affect the clearance of the medicine. Due to the risk of interactions, official product information notes that patients should inform their healthcare professional about all medications, including any vitamins, minerals, or herbal supplements they are taking.

Q: What kind of research has been done on the long-term safety of Аэрофиллин?

A: Research has examined Аэрофиллин for long-term use in conditions like COPD and chronic asthma. However, official information notes that the durability of the response and the long-term effects regarding changes to the underlying condition's course are not fully established, as follow-up durations in many key studies were limited.

Q: Does Аэрофиллин affect my ability to drive or operate machinery?

A: The medicine is associated with adverse reactions like tremors, headache, and restlessness. While some regional regulatory documents state the influence on driving is negligible, it is noted that caution should be exercised due to the possibility of side effects.

Q: How does Аэрофиллин differ from a rescue inhaler?

A: Аэрофиллин is described as a long-acting maintenance medicine used to provide sustained relief and keep airways open over time. It is not a rapid-onset medicine and is therefore not indicated for the quick relief of symptoms during an acute breathing flare-up, which is the role of a rescue inhaler.

Q: What if I experience side effects, should I stop taking Аэрофиллин immediately?

A: Regulatory guidance advises seeking medical attention if potential signs of excessively high drug levels occur, such as severe or continued vomiting, persistent headache, or rapid heartbeat.

Patients are generally instructed to consult a healthcare professional regarding any side effects experienced.

Q: Does Аэрофиллин interact with caffeine?

A: Yes, regulatory-based interaction summaries state that excessive caffeine consumption can alter the blood levels of theophylline, generally by increasing them. Since theophylline is chemically related to caffeine, this can potentially contribute to stimulant side effects such as headache and insomnia.

Q: How often is Аэрофиллин typically taken?

A: The frequency depends on the formulation prescribed. Extended-release oral tablets are generally taken once or twice daily (every 12 or 24 hours).

Immediate-release forms may be divided and given more frequently throughout the day to maintain consistent levels.

Q: Is there a generic version of Аэрофиллин available?

A: Yes, the active ingredient, Theophylline, is available in FDA-approved generic extended-release and immediate-release tablets and solutions from multiple manufacturers.

Q: Is there a particular time of day Аэрофиллин is generally taken?

A: Official administration instructions emphasize taking the medicine at the same time each day to help maintain constant blood levels. Some extended-release forms are typically taken once in the morning, or divided for both morning and evening administration.

Q: Can I use alcohol while taking Аэрофиллин?

A: Alcohol is documented in regulatory information to alter the pharmacokinetics of theophylline. Acute consumption is documented to cause a decrease in theophylline clearance, which may lead to increased blood concentrations.

Q: Does smoking affect how Аэрофиллин works?

A: Yes, official labeling notes that smoking (including tobacco and marijuana smoke) generally increases the body's rate of clearance of theophylline. Due to this effect, monitoring of blood levels may be required if a patient starts or stops smoking.

Q: What types of allergic reactions are associated with Аэрофиллин?

A: The drug is contraindicated in patients with a known allergy to theophylline or other xanthine derivatives. Documented signs of an allergic reaction that require immediate medical attention include hives, difficult breathing, and swelling of the face, lips, tongue, or throat.

Q: Can someone with diabetes safely use Аэрофиллин?

A: The safety profile documents that signs of high blood sugar (hyperglycemia) are listed as a potentially serious adverse reaction. This physiological effect suggests that patients with diabetes may need to have their condition closely observed during use.

Q: Can I take Аэрофиллин if I have stomach issues?

A: Official warnings and precautions state that caution should be exercised in patients with a history of peptic ulcers (stomach ulcers). This is because theophylline is documented to be a gastrointestinal tract irritant and can increase gastric acid secretion.

Storage and Disposal of Theophylline/Aminophylline

The storage and handling of Theophylline (Аэрофиллин) must strictly follow the conditions specified in official regulatory labeling to ensure product stability and potency.

Official Storage Conditions

• Intravenous (IV) Solution: Store at controlled room temperature, typically defined as 20 C to 25 C. The IV solution must be protected from freezing and protected from light.
• Oral Tablets: Store the tablets at a temperature not exceeding 25 C and keep them in the original package.

Handling and Disposal

All forms of the medication must be kept out of the sight and reach of children. The IV solution is intended for single use, and the unused portion must be discarded immediately. Expired or unneeded product must be disposed of in accordance with local regulatory requirements for pharmaceutical waste.